Literature DB >> 20303562

Correction of a carboxyl terminal simian immunodeficiency virus Nef frameshift mutation restores virus replication in macaques.

Yanfang Zheng1, Ilnour Ourmanov, Robert M Goeken, Sonya Whitted, Charles R Brown, Alicia Buckler-White, Ranjini Iyengar, Ronald J Plishka, Vanessa M Hirsch.   

Abstract

Previous studies demonstrated that the nef gene is a critical determinant of the pathogenicity of simian immunodeficiency virus (SIV) in macaques. In the present study, we evaluated the effect of a spontaneous frameshift mutation in the C-terminus of the nef gene of the minimally pathogenic SIVsmH4i clone. This clone exhibited a single nucleotide deletion in the nef gene relative to pathogenic SIV clones that resulted in a frameshift and addition of 46 amino acids to the C-terminus of Nef. We generated a corrected version of this clone, SIVsmH4i Nef+ that restored Nef protein expression. Inoculation of macaques with SIVsmH4i resulted in delayed and low levels of peak viremia. This contrasted with improved kinetics and robust peak viremia in macaques inoculated with the corrected version. Despite the restoration of in vivo replication ability, neither clone resulted in memory CD4+ T cell loss or disease in a period of two years. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20303562      PMCID: PMC3418331          DOI: 10.1016/j.virol.2010.02.026

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  42 in total

1.  Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection.

Authors:  F Kirchhoff; T C Greenough; D B Brettler; J L Sullivan; R C Desrosiers
Journal:  N Engl J Med       Date:  1995-01-26       Impact factor: 91.245

2.  Activation of p21-activated kinase 2 by human immunodeficiency virus type 1 Nef induces merlin phosphorylation.

Authors:  Bangdong L Wei; Vivek K Arora; Alexa Raney; Lillian S Kuo; Guang-Hui Xiao; Eduardo O'Neill; Joseph R Testa; John L Foster; J Victor Garcia
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

Review 3.  Host range restricted, non-replicating vaccinia virus vectors as vaccine candidates.

Authors:  B Moss; M W Carroll; L S Wyatt; J R Bennink; V M Hirsch; S Goldstein; W R Elkins; T R Fuerst; J D Lifson; M Piatak; N P Restifo; W Overwijk; R Chamberlain; S A Rosenberg; G Sutter
Journal:  Adv Exp Med Biol       Date:  1996       Impact factor: 2.622

4.  Anti-V3 humanized antibody KD-247 effectively suppresses ex vivo generation of human immunodeficiency virus type 1 and affords sterile protection of monkeys against a heterologous simian/human immunodeficiency virus infection.

Authors:  Yasuyuki Eda; Toshio Murakami; Yasushi Ami; Tadashi Nakasone; Mari Takizawa; Kenji Someya; Masahiko Kaizu; Yasuyuki Izumi; Naoto Yoshino; Shuzo Matsushita; Hirofumi Higuchi; Hajime Matsui; Katsuaki Shinohara; Hiroaki Takeuchi; Yoshio Koyanagi; Naoki Yamamoto; Mitsuo Honda
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

5.  Improved Mg2+-based reverse transcriptase assay for detection of primate retroviruses.

Authors:  J F Sears; R Repaske; A S Khan
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

6.  A molecularly cloned, pathogenic, neutralization-resistant simian immunodeficiency virus, SIVsmE543-3.

Authors:  V Hirsch; D Adger-Johnson; B Campbell; S Goldstein; C Brown; W R Elkins; D C Montefiori
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

7.  Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara.

Authors:  V M Hirsch; T R Fuerst; G Sutter; M W Carroll; L C Yang; S Goldstein; M Piatak; W R Elkins; W G Alvord; D C Montefiori; B Moss; J D Lifson
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

8.  Dynamin 2 is required for the enhancement of HIV-1 infectivity by Nef.

Authors:  Massimo Pizzato; Anna Helander; Elena Popova; Arianna Calistri; Alessia Zamborlini; Giorgio Palù; Heinrich G Göttlinger
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-05       Impact factor: 11.205

9.  Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein.

Authors:  O Schwartz; V Maréchal; S Le Gall; F Lemonnier; J M Heard
Journal:  Nat Med       Date:  1996-03       Impact factor: 53.440

10.  Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2.

Authors:  Bin Jia; Ruth Serra-Moreno; William Neidermyer; Andrew Rahmberg; John Mackey; Ismael Ben Fofana; Welkin E Johnson; Susan Westmoreland; David T Evans
Journal:  PLoS Pathog       Date:  2009-05-15       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.